Related Experiment Videos
Serum S-100 has prognostic significance in malignant melanoma
J M Bonfrer1, C M Korse, S P Israels
1Department of Clinical Chemistry, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam, The Netherlands.
Anticancer Research
|July 1, 1997
Abstract
Background:
Pretreatment serum values of S-100 and NSE were compared in patients with malignant melanoma.
Materials And Methods:
Pretreatment serum levels of patients with malignant melanoma were analysed for stage of disease and survival.
Results:
S-100 pretreatment serum values seem highly specific, but have low sensitivity.
Conclusion:
Further evaluation is needed with an assay with improved sensitivity.